company background image
IQV logo

IQVIA Holdings NYSE:IQV Voorraadrapport

Laatste prijs

US$194.38

Marktkapitalisatie

US$34.7b

7D

-8.1%

1Y

-7.2%

Bijgewerkt

20 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

IQVIA Holdings Inc.

NYSE:IQV Voorraadrapport

Marktkapitalisatie: US$34.7b

IQV Overzicht aandelen

IQVIA Holdings Inc. levert geavanceerde analyses, technologische oplossingen en klinische onderzoeksdiensten aan de biowetenschappelijke industrie in Noord- en Zuid-Amerika, Europa, Afrika en Azië-Pacific. Meer informatie

Beloningen

Verhandeld tegen 45.9% onder onze schatting van de reële waarde

De winst zal naar verwachting met 13.84% per jaar groeien

De winst groeide het afgelopen jaar met 25.9%

Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Analisten zijn het erover eens dat de aandelenkoers met 30.9% zal stijgen

Risicoanalyse

De schulden worden niet goed gedekt door de operationele kasstroom


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

AI-Driven Innovations And Calculated Partnerships Propel Future Revenue Growth

Key Takeaways Strategic partnerships and AI advancements in TAS are driving efficiencies, enhancing revenue growth, and improving net margins. Strong backlog and new pharma collaborations indicate robust revenue and potential long-term margin enhancements.
View narrative
US$254.40
FV
23.6% undervalued intrinsic discount
5.26%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Updated narrative

IQVIA Holdings Inc. Concurrenten

Agilent Technologies

NYSE:A

US$36.1b

Mettler-Toledo International

NYSE:MTD

US$24.5b

West Pharmaceutical Services

NYSE:WST

US$22.0b

Waters

NYSE:WAT

US$20.5b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor IQVIA Holdings
Historische aandelenkoersen
Huidige aandelenkoersUS$194.38
52 Week HoogtepuntUS$261.73
52 Week LaagUS$187.62
Bèta1.51
11 maand verandering-15.92%
3 maanden verandering-20.65%
1 Jaar Verandering-7.23%
33 jaar verandering-26.75%
5 jaar verandering31.77%
Verandering sinds IPO361.60%

Recent nieuws en updates

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Nov 14
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Oct 21
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

Sep 22
IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

Recent updates

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Nov 14
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Oct 21
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

Sep 22
IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 38% Below Their Intrinsic Value Estimate

Sep 08
IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 38% Below Their Intrinsic Value Estimate

Reiterating Buy On IQVIA After Q2 Earnings

Aug 20

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 11
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Jul 30
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well

Jul 18
These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well

An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

Jun 04
An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

IQVIA: Long-Term Compounder Throwing Off Free Cash Flow

May 27

Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Apr 24
Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

Apr 11
Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Mar 27
IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

Mar 14
Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024

Feb 22

Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Jan 23
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

Dec 24
Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Dec 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

Nov 23
Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

IQVIA Q3: TAS Segment Remains The Problem Child

Nov 21

IQVIA: I Would Stay Away Until Debt Issues Are Resolved

Nov 12

Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

Oct 08
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term

Sep 07

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Sep 04
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

Aug 11
Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

IQVIA Holdings Q2: Breaking Ground And Beating Expectations

Aug 03

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

Jun 27
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

Jun 05
IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

IQVIA Holdings: A Possible Beat And Raise Scenario In The Works

May 23

What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

May 04
What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Mar 19
A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Mar 05
Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

Feb 12
Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

IQVIA Q4 2022 Earnings Preview

Feb 09

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Jan 29
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader

Jan 24

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Nov 09
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA Holdings Sees Digital Opportunities, But Debt Drags Growth

Nov 02

IQVIA Q3 2022 Earnings Preview

Oct 25

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Oct 02
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)

Sep 19

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 22
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US

Aug 11

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Aug 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same

Jul 28

Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

Jul 26
Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

IQVIA Non-GAAP EPS of $2.44 beats by $0.06, revenue of $3.54B beats by $50M, raises FY22 guidance

Jul 21

Rendement voor aandeelhouders

IQVUS Life SciencesUS Markt
7D-8.1%-5.8%-1.0%
1Y-7.2%1.7%30.3%

Rendement versus industrie: IQV presteerde slechter dan de US Life Sciences -sector, die het afgelopen jaar een rendement van 1.7 % opleverde.

Rendement versus markt: IQV presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.3 % opleverde.

Prijsvolatiliteit

Is IQV's price volatile compared to industry and market?
IQV volatility
IQV Average Weekly Movement4.0%
Life Sciences Industry Average Movement8.8%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: IQV heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van IQV is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
n/a88,000Ari Bousbibwww.iqvia.com

IQVIA Holdings Inc. houdt zich bezig met het leveren van geavanceerde analyses, technologische oplossingen en klinische onderzoeksdiensten aan de biowetenschappelijke industrie in Noord- en Zuid-Amerika, Europa, Afrika en Azië-Pacific. Het bedrijf is actief in drie segmenten: Technology & Analytics Solutions, Research & Development Solutions, en Contract Sales & Medical Solutions. Het segment Technology & Analytics Solutions biedt een scala aan cloud-gebaseerde toepassingen en bijbehorende implementatiediensten; real world oplossingen waarmee klanten in de biowetenschappen en de zorgsector bewijsmateriaal kunnen genereren en verspreiden, waardoor besluitvorming in de gezondheidszorg mogelijk wordt en de resultaten voor patiënten verbeteren; en strategische en implementatie adviesdiensten, zoals geavanceerde analytics en outsourcing van commerciële processen.

IQVIA Holdings Inc. Samenvatting

Hoe verhouden de winst en inkomsten van IQVIA Holdings zich tot de beurswaarde?
IQV fundamentele statistieken
MarktkapitalisatieUS$34.73b
Inkomsten(TTM)US$1.41b
Inkomsten(TTM)US$15.32b

25.1x

Koers/Winstverhouding

2.3x

P/S-verhouding

Is IQV overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
IQV resultatenrekening (TTM)
InkomstenUS$15.32b
Kosten van inkomstenUS$9.93b
BrutowinstUS$5.39b
Overige uitgavenUS$3.98b
InkomstenUS$1.41b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)7.74
Brutomarge35.17%
Nettowinstmarge9.17%
Schuld/Eigen Vermogen Verhouding194.9%

Hoe presteerde IQV op de lange termijn?

Bekijk historische prestaties en vergelijking